Basket Study at St. Joseph Health Medical Group
St. Joseph Health Medical Group is currently enrolling patients for the
following basket studies:
A Phase 1/2 Study of Galinpepimut-S in Combination with Pembrolizumab (MK-3475)
in Patients with Selected Advanced Cancers (SELLAS)
Treatment agent: Galinpepimut-S (WT1 immunotx) + pembro
PI:
Jarrod Holmes, MD
Study Coordinator: Sabine Ucik //
Sabine.Ucik@stjoe.org // (707) 521-3830
Resources and Links:
clinicaltrials.gov NCT No: NCT03761914